Hey guys
Okay so -
At the moment NTI is moving downward on low volume - as there is a lack of new buyers which is a consequence of slow market announcements. This has been further hampered by tax time write off's where some investors are looking to sell to claim the loss.
Essentially, as NTI has had no significant market announcements due to it being in somewhat of a flight pattern with study publication impending this means the buy side will dry up and the sell side generally gets skittish. The lower movement in share price creates the silly rumours from time to time that 'some one is in the know' - 'and is therefore selling' - which is garbage. All of the general things that inform selling are occurring; impatience, skittishness, fear, tax time write off etc etc.
No one is in the 'know' - apart from the study conductors and - perhaps NTI 'know' somewhat but that is conjecture.
Did you guys notice that on the 14/5/2018 NTI released an Appendix 3B where Neurotech International paid a company for 'Promotional Services'. Did any of you guys bother to look at who S3 Consortium are? Let me tell you - they run a company called 'Stocks Digital' who specialise in major company announcements and burst marketing - for good news "price catalysts" that garner major share price increases. Stocks digital even announce that their burst marketing can create share price increases of 260%, 360% up to 600% (see website image below.)
Obviously, NTI's major 'good news' story is likely to be the release of their study which will create such a price catalyst. Is it not funny NTI are paying such a company who preps companies like NTI for marketing drives on the back of major positive news announcements?
Also, if you work in the research space - having a peer reviewed published is no small feat - it takes time! Neurotech finished the study late December - it then had to write the whole paper from the data collected which takes time. NTI then had to submit the paper which through the review process can take a further 5+ months. So no it is not unusual that it has taken this long.
The asx in their Code of Best Practice even acknowledges the time it takes to complete a peer reviewed validation process - and that releasing results earlier can be premature. I believe NTI is in this situation. (see image below)
Remember, in NTI's latest 4C they announced that they believe this quarter will be pivotal as it readies itself for the release of the clinical trial results. Pivotal means: "Of crucial importance in relation to the development or success". NTI also announced that they are releasing the next batch of their Mente Autism devices - which exhibit even greater functionality. This is not the announcements of a failing company. They are the announcements of a company who is readying itself. (see image below)
If you have done your research on Neurofeedback and are comfortable with your decision - then you can expect a strong announcement by NTI with major burst marketing and subsequently a significant share price lift. Until that time we all just need to see NTI's current share price for what it is and just chill out.
